{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:57:25Z","timestamp":1791205045742,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.nbd.2012.03.010","type":"journal-article","created":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T17:40:19Z","timestamp":1331314819000},"page":"692-700","source":"Crossref","is-referenced-by-count":26,"title":["A pro-convulsive carbamazepine metabolite: Quinolinic acid in drug resistant epileptic human brain"],"prefix":"10.1016","volume":"46","author":[{"given":"Chaitali","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas V.","family":"Alexopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Gonzalez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damir","family":"Janigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2012.03.010_bb0005","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/sj.bjp.0702940","article-title":"Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl","volume":"128","author":"Behan","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2012.03.010_bb0010","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1046\/j.1471-4159.1997.69041629.x","article-title":"Energetic dysfunction in quinolinic acid-lesioned rat striatum","volume":"69","author":"Bordelon","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2012.03.010_bb0015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jchromb.2005.09.019","article-title":"Liquid chromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma","volume":"828","author":"Breton","year":"2005","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.nbd.2012.03.010_bb0025","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1528-1167.2006.00960.x","article-title":"Development of a humanized in vitro blood\u2013brain barrier model to screen for brain penetration of antiepileptic drugs","volume":"48","author":"Cucullo","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2012.03.010_bb0020","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/sj.jcbfm.9600525","article-title":"Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies","volume":"28","author":"Cucullo","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2012.03.010_bb0030","first-page":"89","article-title":"Mechanisms of endothelial survival under shear stress","volume":"9","author":"Desai","year":"2002","journal-title":"Endothelium (New York)"},{"key":"10.1016\/j.nbd.2012.03.010_bb0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/toxsci\/kfq024","article-title":"Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling","volume":"115","author":"DiNatale","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.nbd.2012.03.010_bb0040","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1046\/j.1528-1157.2001.12301.x","article-title":"Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy","volume":"42","author":"Dombrowski","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2012.03.010_bb0045","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0014-5793(89)81387-0","article-title":"Neuroactive metabolites of L-tryptophan, serotonin and quinolinic acid, in striatal extracellular fluid \u2014 effect of tryptophan loading","volume":"247","author":"During","year":"1989","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2012.03.010_bb0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00023210-200923020-00001","article-title":"Pharmacological manipulation of kynurenic acid potential in the treatment of psychiatric disorders","volume":"23","author":"Erhardt","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nbd.2012.03.010_bb0055","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/nm.1878","article-title":"A role for leukocyte-endothelial adhesion mechanisms in epilepsy","volume":"14","author":"Fabene","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2012.03.010_bb0060","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0920-1211(02)00216-4","article-title":"Alpha-[C-11]-methyl-L-tryptophan PET identifies the epileptogenic tuber and correlates with interictal spike frequency","volume":"52","author":"Fedi","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2012.03.010_bb0065","series-title":"Epilepsy: A Comprehensive Textbook","first-page":"1543","article-title":"Carbamazepine","author":"Fertig","year":"2008"},{"key":"10.1016\/j.nbd.2012.03.010_bb0070","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1528-1167.2009.02428.x","article-title":"Pattern of P450 expression at the human blood\u2013brain barrier: roles of epileptic condition and laminar flow","volume":"51","author":"Ghosh","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2012.03.010_bb0075","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1528-1167.2010.02956.x","article-title":"Cellular localization and functional significance of CYP3A4 in the human epileptic brain","volume":"52","author":"Ghosh","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2012.03.010_bb0080","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2174\/138920011798357051","article-title":"Blood\u2013brain barrier P450 enzymes and multidrug transporters in drug resistance: a synergistic role in neurological diseases","volume":"12","author":"Ghosh","year":"2011","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.nbd.2012.03.010_bb0085","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1586\/ern.09.114","article-title":"Management of the patient with medically refractory epilepsy","volume":"9","author":"Granata","year":"2009","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.nbd.2012.03.010_bb0090","first-page":"287","article-title":"Understanding the physiology of the blood\u2013brain barrier: in vitro models","volume":"13","author":"Grant","year":"1998","journal-title":"News Physiol. Sci."},{"key":"10.1016\/j.nbd.2012.03.010_bb0095","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1042\/bj3200595","article-title":"Human microglia convert L-tryptophan into the neurotoxin quinolinic acid","volume":"320","author":"Heyes","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2012.03.010_bb0100","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0021-9673(95)00278-U","article-title":"High-performance liquid-chromatographic separation and determination of small amounts of process impurities of ciprofloxacin in bulk drugs and formulations","volume":"705","author":"Husain","year":"1995","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.nbd.2012.03.010_bb0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-3565(24)37923-6","article-title":"Detection of 2-hydroxyiminostilbene in the urine of patients taking carbamazepine and its oxidation to a reactive iminoquinone intermediate","volume":"288","author":"Ju","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2012.03.010_bb0110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejphar.2004.07.088","article-title":"Carbamazepine enhances brain production of kynurenic acid in vitro","volume":"498","author":"Kocki","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2012.03.010_bb0115","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra1004418","article-title":"Current concepts drug-resistant epilepsy","volume":"365","author":"Kwan","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2012.03.010_bb0120","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","article-title":"Drug resistance in brain diseases and the role of drug efflux transporters","volume":"6","author":"Loscher","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.010_bb0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.nbd.2008.10.002","article-title":"Antagonism of peripheral inflammation reduces the severity of status epilepticus","volume":"33","author":"Marchi","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2012.03.010_bb0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/clpt.2009.225","article-title":"Transporters in drug-refractory epilepsy: clinical significance","volume":"87","author":"Marchi","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2012.03.010_bb0135","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2010.06.051","article-title":"Blood\u2013brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity","volume":"1353","author":"Marchi","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2012.03.010_bb0140","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1212\/01.WNL.0000052682.99812.F5","article-title":"Alpha-[C-11] methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy","volume":"60","author":"Natsume","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2012.03.010_bb0145","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1097\/00001756-200111160-00037","article-title":"P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain","volume":"12","author":"Potschka","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2012.03.010_bb0150","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2012.03.010_bb0155","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1528-1167.2006.00504.x","article-title":"Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy","volume":"47","author":"Rambeck","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2012.03.010_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.06.027","article-title":"Side by side comparison between dynamic versus static models of blood\u2013brain barrier in vitro: a permeability study","volume":"1109","author":"Santaguida","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2012.03.010_bb0165","first-page":"485","article-title":"Hippocampal kynurenines as etiological factors in seizure disorders","volume":"39","author":"Schwarcz","year":"1987","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.nbd.2012.03.010_bb0170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/135502801300069692","article-title":"Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat","volume":"7","author":"Smith","year":"2001","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.nbd.2012.03.010_bb0175","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrd870","article-title":"Endogenous kynurenines as targets for drug discovery and development","volume":"1","author":"Stone","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2012.03.010_bb0180","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","article-title":"Quinolinic acid \u2014 a potent endogenous excitant at amino-acid receptors in CNS","volume":"72","author":"Stone","year":"1981","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2012.03.010_bb0185","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/rcm.2370","article-title":"A novel C-14-postlabeling assay using accelerator mass spectrometry for the detection of O-6-methyldeoxy-guanosine adducts","volume":"20","author":"Tompkins","year":"2006","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.nbd.2012.03.010_bb0190","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejphar.2011.09.161","article-title":"Proteome studies on liver tissue in a phenobarbital-induced rat model","volume":"670","author":"Wu","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2012.03.010_bb0195","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.jchromb.2009.04.013","article-title":"Simultaneous determination of tryptophan and kynurenine in plasma samples of children patients with Kawasaki disease by high-performance liquid chromatography with programmed wavelength ultraviolet detection","volume":"877","author":"Zhang","year":"2009","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996112000812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996112000812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T21:13:57Z","timestamp":1742678037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996112000812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0969996112000812"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2012.03.010","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}